Source: DGNews | Posted 9 years ago
Health Canada Approves Avapro (Irbesartan) for the Treatment of Diabetic Renal Disease
Tags:
In time for National Diabetes Month, Avapro is the First and Only Drug Approved by Health Canada for the Treatment of Early and Late Stage Renal (Kidney) Disease in Patients with High Blood Pressure and Type 2 Diabetes.
TORONTO, ON -- November 12, 2002 -- There is good news for Canadians with high blood pressure and type 2 diabetes. Bristol-Myers Squibb and Sanofi-Synthelabo today announced that Health Canada has approved Avapro
Comments